Afficher la couverture 'Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept | Chavarot, Nathalie' en grand format
/5

0 avis

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept

Archive ouverte

Chavarot, Nathalie | Ouedrani, Amani | Marion, Olivier | Leruez-Ville, Marianne | Vilain, Estelle | Baaziz, Maroua | del Bello, Arnaud | Burger, Carole | Sberro-Soussan, Rebecca | Martinez, Frank | Chatenoud, Lucienne | Abravanel, Florence | Anglicheau, Dany | Izopet, Jacques | Couat, Chloé | Zuber, Julien | Legendre, Christophe | Lanternier, Fanny | Kamar, Nassim | Scemla, Anne

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. Data about coronavirus disease 2019 (COVID-19) vaccine in the general population provided an excellent profile of immunogenicity strong antibody response following the second dose of mRNA-1273 or BNT162b2 vaccines, associated with a potent T-cell immune response.

Consulter en ligne

Suggestions

Du même auteur

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection

Archive ouverte | Chavarot, Nathalie | CCSD

International audience

COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities

Archive ouverte | Chavarot, Nathalie | CCSD

International audience. Higher rates of severe COVID-19 have been reported in kidney transplant recipients (KTRs) compared to nontransplant patients. We aimed to determine if poorer outcomes were specifically relate...

CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belatacept

Archive ouverte | Morel, Antoine | CCSD

International audience. Introduction Belatacept is associated with a higher incidence of cytomegalovirus (CMV) disease and atypical presentations. Ocular manifestations are rare, representing up to 5% of disease man...

Chargement des enrichissements...